Isocitrate dehydrogenase (IDH) genotype has been shown to be a major classifier and prognosticator for gliomas (10, 11) and WHO 2016 classifies astrocytic tumors as to whether they are IDH mutant or IDH wild type. The gene discussed is IDH1; the disease is central nervous system cancer.